$REPH Recro Pharma, Inc. Insider Trading Week 19/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Recro Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Recro Pharma, Inc. in week 19/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2018 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | M | 0.00 | 13,274 | 0 | 0 | |
| May 14 2018 | REPH | Recro Pharma, Inc. | Ashton William | Director | Buy | M | 0.00 | 13,274 | 0 | 19,457 | 6.2 K to 19.5 K (+214.69 %) |
| May 14 2018 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Option Exercise | M | 0.00 | 13,274 | 0 | 0 | |
| May 14 2018 | REPH | Recro Pharma, Inc. | Flynn Karen | Director | Buy | M | 0.00 | 13,274 | 0 | 20,257 | 7 K to 20.3 K (+190.09 %) |
| May 14 2018 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | M | 0.00 | 13,274 | 0 | 0 | |
| May 14 2018 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Buy | M | 0.00 | 13,274 | 0 | 26,457 | 13.2 K to 26.5 K (+100.69 %) |
| May 14 2018 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Option Exercise | M | 0.00 | 13,274 | 0 | 0 | |
| May 14 2018 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Buy | M | 0.00 | 13,274 | 0 | 19,457 | 6.2 K to 19.5 K (+214.69 %) |
| May 14 2018 | REPH | Recro Pharma, Inc. | ALTOMARI ALFRED | Director | Option Exercise | M | 0.00 | 13,274 | 0 | 0 | |
| May 14 2018 | REPH | Recro Pharma, Inc. | ALTOMARI ALFRED | Director | Option Exercise | M | 0.00 | 13,274 | 0 | 0 | |
| May 14 2018 | REPH | Recro Pharma, Inc. | ALTOMARI ALFRED | Director | Buy | M | 0.00 | 13,274 | 0 | 20,957 | 7.7 K to 21 K (+172.77 %) |
| May 14 2018 | REPH | Recro Pharma, Inc. | ALTOMARI ALFRED | Director | Buy | M | 0.00 | 13,274 | 0 | 20,957 | 7.7 K to 21 K (+172.77 %) |
| May 14 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | M | 0.00 | 8,849 | 0 | 0 | |
| May 14 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | M | 0.00 | 8,849 | 0 | 0 | |
| May 14 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Buy | M | 0.00 | 8,849 | 0 | 15,032 | 6.2 K to 15 K (+143.12 %) |
| May 14 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Buy | M | 0.00 | 8,849 | 0 | 15,032 | 6.2 K to 15 K (+143.12 %) |